Glacier Peak Capital’s Pfizer PFE Stock Holding History

Glacier Peak Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-64,083	Closed	-$1.98M	–	68
2016 Q4	$1.98M	Buy	+64,083	New	+$1.96M	1.13%	23
2016 Q2	–	Sell	-63,240	Closed	-$1.78M	–	49
2016 Q1	$1.78M	Sell	63,240 -115,940	-65%	-$3.31M	1.53%	17
2015 Q4	$5.49M	Sell	179,180 -1,081	-0.6%	-$34K	3.49%	6
2015 Q3	$5.37M	Hold	180,261	–	–	2.98%	10
2015 Q2	$5.74M	Hold	180,261	–	–	2.89%	8
2015 Q1	$5.95M	Hold	180,261	–	–	2.9%	7
2014 Q4	$5.33M	Hold	180,261	–	–	2.7%	8
2014 Q3	$5.06M	Hold	180,261	–	–	2.79%	7
2014 Q2	$5.08M	Buy	+180,261	New	+$5.14M	3.16%	7

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Glacier Peak Capital's PFE Position: Q1 2017 in Review

Glacier Peak Capital sold out of Pfizer (PFE) in Q1 2017, closing a stake of 64,083 shares — an estimated $1.98M sold.

Glacier Peak Capital first reported a position in PFE in Q2 2014 and held it in 9 quarters. The position peaked at $5.95M in Q1 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Glacier Peak Capital reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
Glacier Peak Capital sold 64,083 Pfizer shares in Q1 2017, an estimated $1.98M.
Glacier Peak Capital first reported a position in Pfizer in Q2 2014 and held it in 9 quarters.
Glacier Peak Capital's Pfizer position peaked at $5.95M in Q1 2015.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Glacier Peak Capital's 13F filing for Q1 2017, filed 12 May 2017.